image
Mersana Therapeutics, Inc. MRSN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.3053
0.792 %
$ 38 M
Market Cap
-0.55
P/E
BALANCE SHEET
145 M ASSETS
-36.01%
Growth Rates
1Year -36.01%
3Years -11.13%
5Years 6.11%
7Years 1.46%
10Years 0.00%
154 M LIABILITIES
-18.49%
Growth Rates
1Year -18.49%
3Years 22.26%
5Years 39.46%
7Years 14.24%
10Years 0.00%
-9.51 M EQUITY
-25.77%
Growth Rates
1Year -25.77%
3Years -2.54%
5Years -2.32%
7Years -1.84%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Mersana Therapeutics, Inc.
image
Current Assets 137 M
Cash & Short-Term Investments 135 M
Receivables 0
Other Current Assets 2.28 M
Non-Current Assets 7.76 M
Long-Term Investments 0
PP&E 6.78 M
Other Non-Current Assets 978 K
93.06 %4.69 %Total Assets$144.7m
Current Liabilities 62.5 M
Accounts Payable 4.33 M
Short-Term Debt 16.4 M
Other Current Liabilities 41.8 M
Non-Current Liabilities 91.7 M
Long-Term Debt 1.29 M
Other Non-Current Liabilities 90.4 M
2.81 %10.61 %27.09 %58.65 %Total Liabilities$154.2m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
ASSETS
Cash & Cash Equivalents 107.8 174.6 280.7 177.9 255.1 62.4 59.6 26.6 100.3 11.5
Short Term Investments 26.9 34.5 151.8 0 0 37.4 10.5 88.1 0 0
Receivables 0 0 30.0 0 0 0 0.5 0.8 1.1 0.6
Inventory 0 0 0 0 0 0 (4.2) 1 0 1
Other Current Assets 2.3 5.0 8.5 21.9 3.5 3.1 7.4 4.0 0.8 0.6
Total Current Assets 136.9 214.1 319.2 188.9 258.6 101.3 70.1 117.5 102.2 12.8
PP&E 6.8 11.5 14.5 14.9 12.7 4.8 2.7 2.3 2.5 1.3
Intangible Assets 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0.5 0.5 321 0.3 0.4 10.5 0.3 0
Other Long Term Assets 1.0 0.5 0.2 1.9 2.2 1.1 5.3 0.4 0.1 0.4
Other Assets 0 0 0 0 0 0 0 0 0 0
Total Assets 144.7 226.1 334.3 206.1 273.4 107.5 78.5 130.7 105.1 14.4
LIABILITIES
Accounts Payable 4.3 7.3 14.0 12.3 8.3 7.3 10.7 3.1 2.1 2.0
Short Term Debt 16.4 5.5 3.0 2.5 1.5 2.9 0 0 0 0
Other Current Liabilities 19.6 22.7 44.2 29.0 16.2 9.1 12.5 7.2 3.6 1.7
Total Current Liabilities 62.5 63.6 91.5 47.5 30.0 24.1 69.4 31.9 28.4 10.7
Long Term Debt 1.3 28.4 33.5 35.9 15.1 4.9 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0
Other Liabilities 90.4 1 K 0.2 1.0 0.2 0.3 0.3 67 K 94.7 36.3
Total Liabilities 154.2 189.2 242.3 84.4 45.3 29.2 69.7 60.7 160.7 57.1
EQUITY
Common Stock 12 K 12 K 11 K 7 K 7 K 5 K 3 K 3 K 1 K 1 K
Retained Earnings (895.6) (826.4) (654.7) (450.5) (280.4) (192.4) (164.2) (97.9) (59.2) (45.5)
Other Accumulative Comprehensive Income/Loss 10 K 11 K (0.2) 0 0 25 K 8 K (0.1) (4.2) (3.6)
Total Equity (9.5) 36.9 92.1 121.7 228.1 78.3 8.8 70.0 (55.6) (42.7)
Total Liabilities and Equity 144.7 226.1 334.3 206.1 273.4 107.5 78.5 130.7 105.1 14.4
SHARES OUTSTANDING
Common Shares Outstanding 122.5 116.1 93.7 70.6 61.5 43.4 23.0 12.0 17.5 17.5